New Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical Trials Read more about New Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical Trials
ICON Announces Service Agreement with Pfizer Read more about ICON Announces Service Agreement with Pfizer
ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research Excellence Awards Read more about ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research Excellence Awards
Mr. Thomas Lynch Notifies ICON of His Retirement as Chairman and That He Will Not Stand for Re-Election to the Board of Directors at the Annual General Meeting Read more about Mr. Thomas Lynch Notifies ICON of His Retirement as Chairman and That He Will Not Stand for Re-Election to the Board of Directors at the Annual General Meeting
ICON Selected by the International Consortium for Health Outcomes Measurement to Help Advance Value-based Healthcare Read more about ICON Selected by the International Consortium for Health Outcomes Measurement to Help Advance Value-based Healthcare
ICON Reports Fourth Quarter and Full Year 2015 Results and Issues 2016 Earnings Guidance Read more about ICON Reports Fourth Quarter and Full Year 2015 Results and Issues 2016 Earnings Guidance
ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases Read more about ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases
ICON Secures Investment Grade Credit Ratings Read more about ICON Secures Investment Grade Credit Ratings
ICON plc Announces Private Placement of US$350,000,000 of Senior Notes Read more about ICON plc Announces Private Placement of US$350,000,000 of Senior Notes
